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Water-solubility is essential for GIT absorbability or parenteral administration of drugs, therefore it is a key 
parameter to achieve the systemic drug concentration necessary for an effective therapeutic activity. 
Unfortunately, low aqueous solubility is the major problem with bioactive chemical entities (BCEs), in fact, 
more than 40% BCEs developed in pharmaceutical industry are practically water-insoluble. As a consequence, 
great are the research efforts focused on the development of new techniques aiming at enhancing it. Toxic 
excipients and harmful solubilizing agents were also extensively used for solubilizing and delivering non water-
soluble drugs, despite the resulting unpleasant side effects complained of by patients. Nowadays, safer 
strategies, such as drugs physicochemical modifications or particle size reduction, crystal engineering, salt 
formation, solid dispersion, use of surfactant and complexation are being exploited. As far as what regards 
dispersion/complexation techniques, nanoparticles, including dendrimers, are intensely utilized for this purpose, 
thus in parallel achieving drugs protection from early degradation, more efficient target delivery into cells and 
tissues and lower systemic toxicity. Synthetic thiocarbamate (O-TC 1) (Fig. 1) is a non-nucleoside HIV-1 
reverse transcriptase inhibitor [1] while Ellagic Acid (EA 2) (Fig. 2) is a polyphenol present in some fruits, nuts 
and seeds endowed with strong antioxidant, anti-inflammatory and other several healthy properties. 
Unfortunately, both of them are practically insoluble (Table 1), non orally bioavailable, non parenteral 
administrable, then non usable for therapeutic purposes in their free forms. 
 
 
   
Fig. 1: Structure of O-TC 1 Fig. 2: Structure of EA 2  Fig. 3: Examples of  hydrophilic (left) and amphiphilic 
(right) dendrimers structure  
 
During the last year, these problems have been addressed and successfully resolved by us, and in this 
communication, the reached promising outcomes have been summarized and the current state of the art 
provided. Afar from commercially high cytotoxic PAMAM, five non cells-damaging amino acid-modified 
hydrophilic (3, 4) [2] and amphiphilic (5-7) [3] dendrimers (Fig. 3) have been synthetized and then used as 
polymer nano-containers to improve 1 and 2 water-solubility. Five (8-12) [4] and two (13, 14) [5] structurally 
different drugs-loaded nanodispersions (DPXs) were obtained respectively. The structures were confirmed by 
FT-IR and NMR analysis and all the samples have resulted in being endowed with very good Drug Loading 
(DL %). Compound 1, totally insoluble except for in highly diluted DMSO when free, once entrapped in 
dendrimers, shown to be well soluble both in water and in ethanol. In the case of 2, water-solubility was 
increased even up to 1000 times compared to the free form. For the prerogatives demonstrated in the performed 
routine analyses, the prepared DPXs could be considered eligible for biomedical and therapeutic applications 
thus allowing to exploit 1 and 2 pharmacological properties. 
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